
GC43163
CAY10508
Also known as 1,3-bis(4-bromophenyl)-5-phenylimidazolidine-2,4-dione
Central cannabinoid (CB1) receptor antagonists and inverse agonists exhibit therapeutic potential for obesity and drug dependence, while being devoid of psychotropic effects
ChemicalCAS878533-35-8MW486.2FormulaC21H14Br2N2O2
- CAS number
- 878533-35-8
- Molecular weight
- 486.2
- Formula
- C21H14Br2N2O2
- Solubility
- DMF: 30 mg/ml,DMF:PBS (pH 7·2) (1:2): ·25 mg/ml,DMSO: 10 mg/ml
- InChIKey
- ROASQEPZAKGACK-UHFFFAOYSA-N
- Catalogue number
- GC43163
- Brand
- GLPBIO
Computed properties PubChem CID 11851013 · XLogP 5.5 · TPSA 40.6 Ų · H-bond donors 0
- XLogP
- 5.5
- TPSA
- 40.6 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Rotatable bonds
- 3
- Heavy atoms
- 27
SMILES C1=CC=C(C=C1)C2C(=O)N(C(=O)N2C3=CC=C(C=C3)Br)C4=CC=C(C=C4)Br
Computed descriptors from PubChem (CID 11851013), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il